Kautzky-Willer A - Search Results

1

[Insulin therapy of type 2 diabetes mellitus (Update 2019)].

Lechleitner M, Clodi M, Abrahamian H, Brath H, Brix J, Drexel H, Fasching P, Föger B, Francesconi C, Fröhlich-Reiterer E, Harreiter J, Hofer SE, Hoppichler F, Huber J, Kaser S, Kautzky-Willer A, Ludvik B, Luger A, Mader JK, Paulweber B, Pieber T, Prager R, Rami-Merhar B, Resl M, Riedl M, Roden M, Saely CH, Schelkshorn C, Schernthaner G, Sourij H, Stechemesser L, Stingl H, Toplak H, Wascher TC, Weitgasser R, Winhofer-Stöckl Y, Zlamal-Fortunat S. Lechleitner M, et al. Wien Klin Wochenschr. 2019 May;131(Suppl 1):39-46. doi: 10.1007/s00508-019-1492-7. Wien Klin Wochenschr. 2019. PMID: 30980147 Free article. Review. German.

2

Beta-cell hypersecretion and not reduced hepatic insulin extraction is the main cause of hyperinsulinemia in obese nondiabetic subjects.

Kautzky-Willer A, Pacini G, Ludvik B, Schernthaner G, Prager R. Kautzky-Willer A, et al. Metabolism. 1992 Dec;41(12):1304-12. doi: 10.1016/0026-0495(92)90100-o. Metabolism. 1992. PMID: 1461136

3

Effects of captopril treatment versus placebo on renal function in type 2 diabetic patients with microalbuminuria: a long-term study.

Capek M, Schnack C, Ludvik B, Kautzky-Willer A, Banyai M, Prager R. Capek M, et al. Clin Investig. 1994 Dec;72(12):961-6. doi: 10.1007/BF00577736. Clin Investig. 1994. PMID: 7711427 Clinical Trial.

4

Increased levels of circulating islet amyloid polypeptide in patients with chronic renal failure have no effect on insulin secretion.

Ludvik B, Clodi M, Kautzky-Willer A, Schuller M, Graf H, Hartter E, Pacini G, Prager R. Ludvik B, et al. J Clin Invest. 1994 Nov;94(5):2045-50. doi: 10.1172/JCI117558. J Clin Invest. 1994. PMID: 7962550 Free PMC article.

5

Long-term treatment with nifedipine reduces urinary albumin excretion and glomerular filtration rate in normotensive type 1 diabetic patients with microalbuminuria.

Schnack C, Capek M, Banyai M, Kautzky-Willer A, Prager R, Schernthaner G. Schnack C, et al. Acta Diabetol. 1994 Apr;31(1):14-8. doi: 10.1007/BF00580754. Acta Diabetol. 1994. PMID: 8043891 Clinical Trial.

6

[Diabetes mellitus and carbohydrate metabolism in primary hyperparathyroidism].

Kautzky-Willer A, Niederle B, Schernthaner G, Prager R. Kautzky-Willer A, et al. Wien Klin Wochenschr. 1993;105(6):158-62. Wien Klin Wochenschr. 1993. PMID: 8475626 Review. German.

7

Amylin: history and overview.

Ludvik B, Kautzky-Willer A, Prager R, Thomaseth K, Pacini G. Ludvik B, et al. Diabet Med. 1997 Jun;14 Suppl 2:S9-13. doi: 10.1002/(sici)1096-9136(199706)14:2+3.3.co;2-4. Diabet Med. 1997. PMID: 9212323 Review.

8

The increased insulin sensitivity in growth hormone-deficient adults is reduced by growth hormone replacement therapy.

Riedl M, Ludvik B, Pacini G, Clodi M, Kotzmann H, Wagner O, Kautzky-Willer A, Prager R, Luger A. Riedl M, et al. Eur J Clin Invest. 2000 Sep;30(9):771-8. doi: 10.1046/j.1365-2362.2000.00695.x. Eur J Clin Invest. 2000. PMID: 10998076 Clinical Trial.

9

Increased plasma leptin in gestational diabetes.

Kautzky-Willer A, Pacini G, Tura A, Bieglmayer C, Schneider B, Ludvik B, Prager R, Waldhäusl W. Kautzky-Willer A, et al. Diabetologia. 2001 Feb;44(2):164-72. doi: 10.1007/s001250051595. Diabetologia. 2001. PMID: 11270672

10

The effect of Ipomoea batatas (Caiapo) on glucose metabolism and serum cholesterol in patients with type 2 diabetes: a randomized study.

Ludvik BH, Mahdjoobian K, Waldhaeusl W, Hofer A, Prager R, Kautzky-Willer A, Pacini G. Ludvik BH, et al. Diabetes Care. 2002 Jan;25(1):239-40. doi: 10.2337/diacare.25.1.239. Diabetes Care. 2002. PMID: 11772921 Clinical Trial. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

450 results

Search Page